Healthcare industry struggles to contain breaches

| | Health Exec | Cybersecurity

The healthcare industry is a frequent victim of data breaches and malicious hacking, and organizations struggle to contain the threat, reports CNNMoney.

About 90 percent of healthcare organizations have exposed their patients’ data, or had it stolen, in 2012 and 2013—and as of mid-August, the healthcare industry has been hit with 204 incidents, representing nearly half of all major breaches across all industries, according to the story.

"They can't keep up [with hackers]," J.D. Sherry, who advises hospitals for cybersecurity firm Trend Micro, told CNNMoney. "Their resources are tremendously overwhelmed. With day-to-day business, IT security is not top of mind."

Read the full story below:

90% of hospitals and clinics lose their patients' data

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.